Web3 apr. 2024 · Based on short-term price targets offered by three analysts, the average price target for Kiniksa Pharmaceuticals, Ltd. comes to $22.33. The forecasts range from a low of $19.00 to a high of $28.00. Web13 apr. 2024 · Kiniksa Pharmaceuticals, Ltd. has a 12 month low of $7.36 and a 12 month high of $17.19. The company has a market capitalization of $743.54 million, a price-to-earnings ratio of 4.12 and a beta of -0.10. The firm's fifty day moving average price is $12.26 and its 200 day moving average price is $13.66.
Kiniksa Pharmaceuticals, Ltd. (KNSA) Upgraded to Buy: Here
WebCompany profile page for Kiniksa Pharmaceuticals Ltd including stock price, company news, press releases, executives, board members, and contact information WebKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Portfolio Execution – ARCALYST® (rilonacept) Q4 2024 and full-year 2024 … mhra image referencing
What is the current Price Target and Forecast for Kiniksa ...
Web12 apr. 2024 · Kiniksa Pharmaceuticals (Nasdaq:KNSA) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Kiniksa … Web1 dag geleden · Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Historical Prices & Data - Yahoo Finance U.S. markets open in 6 hours 17 minutes S&P Futures -4.50(-0.11%) … WebKiniksa Pharmaceuticals Ltd (KNSA) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Apr 10, 2024! Sign Up mhr aibo